SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

BOTANIX PHARMACEUTICALS LTD(BOT)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
BOTANIX PHARMACEUTICALS LTD07/07/2016
BONE MEDICAL LIMITED20/08/200407/07/2016
REVENIR LIMITED22/01/200420/08/2004
ALIQUOT ASSET MANAGEMENT LIMITED20/08/200122/01/2004
AERODATA HOLDINGS LIMITED20/08/2001

Shareholder links

Our website ranking of BOT: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Services Level 5, 126 Phillip Street Sydney NSW 2000

Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
Fax :
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000BOT2
Address: 50 Angove Street North Perth WA 6006
Tel:  08 6555 2945 Fax: 08 6210 1153

Date first listed: 24/01/1985
Company Secretary: Simon Robertson
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Development and commercialisation of treatments for bone disease

News & Events

Expand this box to read and print

The securities of Botanix Pharmaceuticals Ltd will be reinstated to official quotation immediately following the release of an announcement regarding a capital raising.

05/04/2017

The company releases a capital raising presentation.

05/04/2017

The company has received commitments to raise A$7.4 million via a significantly oversubscribed placement to existing and new institutional and sophisticated investors.

05/04/2017

The securities of Botanix Pharmaceuticals Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement.

04/04/2017

Botanix Pharmaceuticals Limited (formerly Bone Medical Limited; "the Company") will be reinstated to official quotation as from the commencement of trading on Friday 15 July 2016, following the Company's recompliance with Listing Rule 11.1.3 and Chapters 1 and 2 of the ASX Listing Rules.

13/07/2016

name changed from Bone Medical Limited

07/07/2016
OFX Transferring Money Internationally to Free

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    25/10/2016Graham Griffiths1,000,000$0.049$49,395
    10/04/2015Robert Towner-2,500,000$0.013$32,440

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Vince IppolitoExecutive Chairman20/05/2019
    Ric PetersonCFO01/08/2019
    Stewart WasherNon Exec Director21/02/2019
    Matt CallahanExecutive Director01/07/2016
    William BoschExecutive Director01/07/2016

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Michael ThurnExecutive Director, COO14/02/201726/02/2021
    Robert TownerNon Exec Chairman28/01/201411/02/2020
    Graham GriffithsNon Exec Chairman01/07/201608/02/2019
    John HannafordNon Exec Director28/01/201401/07/2016
    Phillip WingateNon Exec Director27/11/201401/07/2016
    Roger NewNon Exec Director02/06/200527/11/2014
    Peter YoungManaging Director, CEO05/04/201112/05/2014
    Leon IvoryDirector16/11/200524/01/2014
    Peter BrooksDirector25/07/200724/01/2014
    Barry WalkerNon Exec Director16/11/200519/08/2011
    Leif JensenNon Exec Chairman27/05/200801/08/2011
    Troels JordansenManaging Director16/11/200602/06/2009
    Paul HopperExecutive Chairman02/07/200516/07/2007
    Richard BashamNon Exec Director18/05/200411/04/2006
    Christopher BilkeyNon Exec Director02/08/200416/11/2005
    Wayne FritzscheNon Exec Director11/04/200514/11/2005
    Micahel RedmanCEO28/02/200507/11/2005
    Glen TraversNon Exec Director02/08/200403/06/2005
    Michael PerrottNon Exec Chairman31/05/200130/05/2005
    James PhillipsCEO12/08/200428/02/2005
    Terence KestelNon Exec Director16/12/200330/11/2004
    Peter HustonNon Exec Director29/11/200012/05/2004
    Antony RigollExecutive Director29/11/200016/12/2003
    Andrew BrownNon Exec Director19/02/200328/11/2003
    Bruce BurrellNon Exec Director19/02/200328/11/2003
    Paul CrowtherNon Exec Director19/02/200304/04/2003
    David ArgyleNon Exec Director30/04/200131/07/2002

    Date of first appointment, title may have changed.